UBS Upgrades CBRE to Buy with Increased Price Target
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy CBRE?
Source: seekingalpha
- Rating Upgrade: UBS has upgraded CBRE from Neutral to Buy, increasing the price target from $175 to $185, indicating a rare buying opportunity amid AI concerns that could lead to disintermediation in commercial real estate brokerage.
- Stock Performance: Currently trading around $145, CBRE is approximately 11% below its 20-day simple moving average, reflecting market caution regarding its future performance, which may present a low-entry opportunity for investors.
- Earnings Forecast Increase: UBS raised its 2026 EPS estimate for CBRE by 5% to $7.55, driven by strong brokerage guidance and the impact of the Pearce acquisition, highlighting the company's robust growth potential in the industry.
- Market Trend Analysis: While AI may impact commercial real estate brokerage over time, UBS analysts believe that CBRE is well-positioned to benefit due to its strong industry position and vast data assets, projecting a year-over-year growth of 14%-19% in 2026.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CBRE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CBRE
Wall Street analysts forecast CBRE stock price to rise
5 Analyst Rating
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 147.010
Low
175.00
Averages
186.00
High
192.00
Current: 147.010
Low
175.00
Averages
186.00
High
192.00
About CBRE
CBRE Group, Inc. is a commercial real estate services and investments firm. The Company’s segments include Advisory Services, Building Operations & Experience, Project Management, and Real Estate Investments. The Advisory Services segment provides a comprehensive range of services globally, including property leasing, capital markets (property sales and loan origination), loan servicing, property management, and valuation. The Building Operations & Experience segment provides a suite of integrated, contractually based outsourcing services to occupiers and owners of real estate, including facilities management and property management. The Project Management segment delivers program management, project management and cost consultancy services across the commercial real estate, infrastructure and natural resources sectors. The Real Estate Investments segment is a real asset developer, investor and operator. It provides advanced technical services for digital and power infrastructure.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
UBS Acquisition: UBS has raised funds to facilitate the acquisition of Credit Suisse from the Swiss government, marking a significant move in the banking sector.
Neutral Position: The acquisition is seen as a strategic decision to stabilize the financial landscape and restore confidence in the banking system.
See More
- Market Reaction: Trump's announcement to raise global tariffs from 10% to 15% led to a market decline on Monday, with CrowdStrike's stock dropping over 9%, reflecting investor concerns about tariff policy uncertainty and tech stock valuations.
- Alphabet Upgrade: Wells Fargo upgraded Alphabet from hold to buy and raised its price target from $354 to $387, with a projected 60% revenue growth for Google Cloud in 2026, exceeding consensus by 11%, highlighting its leadership in AI capabilities.
- Home Depot Earnings Outlook: Home Depot is set to report earnings before the bell on Tuesday, with analysts predicting a slight decline in same-store sales, although the company’s 2026 guidance suggests flat to 2% growth, making it attractive during a rate-cut cycle according to Jim.
- Rapid Fire Recap: Other stocks mentioned in Monday's video include Workday, CBRE Group, VF Corp, and Domino's Pizza, indicating a focus on diversified investment opportunities.
See More
- Rating Upgrade: UBS has upgraded CBRE from Neutral to Buy, increasing the price target from $175 to $185, indicating a rare buying opportunity amid AI concerns that could lead to disintermediation in commercial real estate brokerage.
- Stock Performance: Currently trading around $145, CBRE is approximately 11% below its 20-day simple moving average, reflecting market caution regarding its future performance, which may present a low-entry opportunity for investors.
- Earnings Forecast Increase: UBS raised its 2026 EPS estimate for CBRE by 5% to $7.55, driven by strong brokerage guidance and the impact of the Pearce acquisition, highlighting the company's robust growth potential in the industry.
- Market Trend Analysis: While AI may impact commercial real estate brokerage over time, UBS analysts believe that CBRE is well-positioned to benefit due to its strong industry position and vast data assets, projecting a year-over-year growth of 14%-19% in 2026.
See More
- UBS Rating Upgrade: UBS upgraded CBRE's rating from neutral to buy and raised its 12-month price target from $175 to $185, implying a 21% upside from Friday's close, indicating potential for new record highs in the stock.
- Market Panic Eases: Despite a 20% plunge in two days due to fears of AI disrupting office space demand, UBS analysts believe these concerns are overstated, asserting that CBRE's strong industry position and extensive data assets will allow it to benefit.
- Strong Fundamentals: In its latest quarterly report, CBRE provided robust guidance, indicating momentum from 2025 will continue into the first six weeks of 2026, with analysts noting that this outlook is not yet reflected in the stock price.
- Revenue Growth Expectations: UBS analysts project that CBRE will achieve 14-19% year-over-year revenue growth in FY26, suggesting that the market is currently pricing in only about 7% medium-term revenue growth, indicating significant upside potential for the stock.
See More
- Tariff Policy Impact: President Trump raised the global baseline tariff rate from 10% to 15%, which is likely to lead to a down open on Wall Street, potentially affecting investor confidence and exacerbating trade tensions.
- Pharmaceutical Competition: Eli Lilly triumphed over Novo Nordisk in a head-to-head trial, with Novo's obesity drug CagriSema proving less effective than Lilly's Zepbound, resulting in a 15% drop in Novo's shares while Lilly's rose over 3%, indicating increased market confidence in Lilly.
- Banking Sector Upgrade: RBC Capital Markets upgraded Spain's Banco Santander from hold to buy, anticipating that its expansion in the U.S. and upcoming investor day will enhance its market valuation, showcasing its competitive edge in the European banking sector.
- Software Industry Risks: Jefferies downgraded several software companies, citing heightened AI risks and negative sentiment, particularly impacting Workday and DocuSign, indicating a shift in market confidence towards companies like Salesforce that can disrupt themselves.
See More









